DariusJohnAdamsMD
Medical Genetics • Morristown, NJClinical Biochemical Genetics, Clinical Genetics
Director, Personalized Genomic Medicine
Dr. Adams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Madison Avenue
Suite 107
Morristown, NJ 07960
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Medical Genetics and Genomics, 1997 - 2001
Rutgers New Jersey Medical SchoolClass of 1997
Certifications & Licensure
NJ State Medical License 2013 - 2025
NY State Medical License 1999 - 2025- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2014
- Hudson Valley Magazine Castle Connolly, 2013
Clinical Trials
- An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
- AAV Gene Therapy Study for Subjects With PKU Start of enrollment: 2020 Sep 24
Publications & Presentations
PubMed
- 12 citationsUse of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics.Darius Adams, Hans C. Andersson, Heather Bausell, Kea Crivelly, Caroline Eggerding
Molecular Genetics and Metabolism Reports. 2021-09-01 - 5 citationsThe infantile neuroaxonal dystrophy rating scale (INAD-RS).Paldeep S. Atwal, Mark G. Midei, Darius J. Adams, Alex J. Fay, Frederic Heerinckx
Orphanet Journal of Rare Diseases. 2020-07-29 - 18 citationsTreatment of infantile neuroaxonal dystrophy with RT001: A di-deuterated ethyl ester of linoleic acid: Report of two cases.Darius J. Adams, Mark G. Midei, Jahannaz Dastgir, Christina Flora, Robert J. Molinari
JIMD Reports. 2020-03-27
Press Mentions
CTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial Using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type CMay 23rd, 2019
CTD Holdings to Host Webinar on Its Phase I Clinical Trial for Niemann-Pick Disease Type COctober 11th, 2018- CTD Announces New Expanded Access Program in Taiwan Using Trappsol Cyclo for Niemann-Pick Disease Type CMay 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
